Cargando…
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection
BACKGROUND: Infectious diseases are still a leading cause of death and, with the emergence of drug resistance, pose a great threat to human health. New drugs and strategies are thus urgently needed to improve treatment efficacy and limit drug-associated side effects. Nanotechnology-based drug delive...
Autores principales: | Coya, Juan Manuel, De Matteis, Laura, Giraud-Gatineau, Alexandre, Biton, Anne, Serrano-Sevilla, Inés, Danckaert, Anne, Dillies, Marie-Agnès, Gicquel, Brigitte, De la Fuente, Jesus M., Tailleux, Ludovic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346558/ https://www.ncbi.nlm.nih.gov/pubmed/30683129 http://dx.doi.org/10.1186/s12951-018-0439-x |
Ejemplares similares
-
The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection
por: Giraud-Gatineau, Alexandre, et al.
Publicado: (2020) -
Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives
por: Serrano-Sevilla, Inés, et al.
Publicado: (2019) -
Controlling Properties and Cytotoxicity of Chitosan Nanocapsules by Chemical Grafting
por: De Matteis, Laura, et al.
Publicado: (2016) -
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis
por: Shahnaz, Gul, et al.
Publicado: (2017) -
Chitosan Based MicroRNA Nanocarriers
por: Genedy, Hussein H., et al.
Publicado: (2022)